Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis.

Neregård, P

Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis. [electronic resource] - Scandinavian journal of rheumatology 2014 - 85-90 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1502-7732

10.3109/03009742.2013.834964 doi


Adult
Aged
Antibodies, Monoclonal--pharmacology
Antirheumatic Agents--pharmacology
Arthritis, Rheumatoid--drug therapy
Arthroscopy
Biopsy
Etanercept
Female
Humans
Image Processing, Computer-Assisted
Immunoglobulin G--pharmacology
Immunohistochemistry
Infliximab
Lymphotoxin-alpha--metabolism
Male
Middle Aged
Receptors, Tumor Necrosis Factor--therapeutic use
Synovial Membrane--drug effects
Treatment Outcome
Tumor Necrosis Factor-alpha--metabolism